Search

Your search keyword '"Robinson, Christina M."' showing total 224 results

Search Constraints

Start Over You searched for: Author "Robinson, Christina M." Remove constraint Author: "Robinson, Christina M."
224 results on '"Robinson, Christina M."'

Search Results

3. Engineering CD276/B7-H3-targeted antibody-drug conjugates with enhanced cancer-eradicating capability

7. Prevalence of neoplasia at colonoscopy among testicular cancer survivors treated with platinum-based chemotherapy

8. Prevalence of neoplasia at colonoscopy among testicular cancer survivors treated with platinum-based chemotherapy

10. Prevalence of neoplasia at colonoscopy among testicular cancer survivors treated with platinum‐based chemotherapy

13. Data from Comparison of Three Transcytotic Pathways for Distribution to Brain Metastases of Breast Cancer

14. Supplementary Figure S1-S10 from Comparison of Three Transcytotic Pathways for Distribution to Brain Metastases of Breast Cancer

15. Supplementary Table 1 from Comparison of Three Transcytotic Pathways for Distribution to Brain Metastases of Breast Cancer

16. Supplementary Material and Methods from Comparison of Three Transcytotic Pathways for Distribution to Brain Metastases of Breast Cancer

18. Using New Hampshire Colonoscopy Registry data to assess United States and European post-polypectomy surveillance guidelines

21. Supplementary Methods from TNIK Is a Therapeutic Target in Lung Squamous Cell Carcinoma and Regulates FAK Activation through Merlin

22. Supplementary Tables from TNIK Is a Therapeutic Target in Lung Squamous Cell Carcinoma and Regulates FAK Activation through Merlin

23. Data from Rigosertib Induces Mitotic Arrest and Apoptosis in RAS-Mutated Rhabdomyosarcoma and Neuroblastoma

24. Supplementary Figure S8.1 from TNIK Is a Therapeutic Target in Lung Squamous Cell Carcinoma and Regulates FAK Activation through Merlin

25. Supplementary Movie 1 from TNIK Is a Therapeutic Target in Lung Squamous Cell Carcinoma and Regulates FAK Activation through Merlin

26. Data from TNIK Is a Therapeutic Target in Lung Squamous Cell Carcinoma and Regulates FAK Activation through Merlin

27. Supplementary Figures from TNIK Is a Therapeutic Target in Lung Squamous Cell Carcinoma and Regulates FAK Activation through Merlin

28. Supplementary Data from Rigosertib Induces Mitotic Arrest and Apoptosis in RAS-Mutated Rhabdomyosarcoma and Neuroblastoma

29. Supplementary Figure S2 from The Combination of Trametinib and Ganitumab is Effective in RAS-Mutated PAX-Fusion Negative Rhabdomyosarcoma Models

30. Supplementary Data File S5 from The Combination of Trametinib and Ganitumab is Effective in RAS-Mutated PAX-Fusion Negative Rhabdomyosarcoma Models

31. Comparison of Three Transcytotic Pathways for Distribution to Brain Metastases of Breast Cancer

32. Response

37. The Combination of Trametinib and Ganitumab is Effective in RAS-Mutated PAX-Fusion Negative Rhabdomyosarcoma Models

38. Abstract IA023: Therapeutic efficacy of trametinib and ganitumab in RAS-mutated rhabdomyosarcoma

41. Abstract 2152: TNIK, a novel activator of FAK and YAP signaling, is a therapeutic target in lung squamous cell carcinoma

45. Serrated Polyp Yield at Colonoscopy in Patients with Positive FIT, Positive mt-sDNA, and Colonoscopy Only: Data from the New Hampshire Colonoscopy Registry.

48. Rigosertib Induces Mitotic Arrest and Apoptosis in RAS-Mutated Rhabdomyosarcoma and Neuroblastoma

50. TNIK Is a Therapeutic Target in Lung Squamous Cell Carcinoma and Regulates FAK Activation through Merlin

Catalog

Books, media, physical & digital resources